文献速递内脏/肾动脉与血管畸形

二氧化碳血管造影在移植肾动脉狭窄治疗中的应用

Carbon Dioxide Angiography in the Treatment of Transplant Renal Artery Stenosis.
PubMed 文献 · Ann Vasc Surg · 2019-10-15

本研究评估辅助使用二氧化碳血管造影治疗移植肾动脉狭窄的疗效。2012至2017年间37例患者接受造影,34例接受血管内治疗,其中24例(70.6%)使用二氧化碳造影,10例(29.4%)使用标准对比剂造影。二氧化碳组对比剂用量显著更少(9.5 mL vs 19.5 mL,P=0.03),技术成功率相当(92.2% vs 91.7%,P=0.9)。

要点

  • 辅助二氧化碳造影可显著减少对比剂用量。
  • 二氧化碳组与技术成功率相当,不降低手术成功。
  • 移植肾动脉狭窄血管内治疗可考虑二氧化碳造影为首选。

核心结论

  • 辅助使用二氧化碳血管造影较标准造影显著减少对比剂用量,且技术成功率相当。

研究设计与样本

  • 单中心三级学术医疗中心2012至2017年接受移植肾动脉狭窄血管内治疗(经皮腔内血管成形术伴或不伴支架)的患者研究。
  • 37例患者接受造影,34例接受治疗干预,其中24例(70.6%)辅助二氧化碳造影,10例(29.4%)标准对比剂造影。

主要发现

  • 二氧化碳组对比剂用量为9.5 mL(IQR 2-19.5),标准造影组为19.5 mL(IQR 15-30),P=0.03。
  • 二氧化碳组技术成功率为92.2%,标准造影组为91.7%,P=0.9。
  • 两组基线特征相似。

临床怎么用

  • 对需血管内治疗的移植肾动脉狭窄患者,可考虑将选择性二氧化碳血管造影作为一线模式以减少对比剂暴露。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Transplant renal artery stenosis (TRAS) is a serious complication associated with graft loss. Selective carbon dioxide angiography allows for effective diagnosis and therapy with the use of minimal to no contrast agent. This study sought to evaluate the efficacy of the adjunctive use of carbon dioxide angiography in the treatment of TRAS. METHODS: Patients undergoing endovascular therapy (percutaneous transluminal angioplasty with or without stent) for TRAS between the years 2012 and 2017 at a single tertiary care academic medical center were studied. Outcomes of interest included technical success, postoperative glomerular filtration rate, and renal ultrasound hemodynamic parameters. RESULTS: Of the 37 patients who underwent angiography for TRAS during the study period, 34 underwent a therapeutic intervention. Of those, 24 patients (70.6%) underwent adjunctive carbon dioxide angiography versus 10 patients (29.4%) who underwent standard contrast angiography. Baseline characteristics between the carbon dioxide angiography and traditional angiography groups were similar. Patients undergoing carbon dioxide angiography received significantly less contrast agent than patients undergoing traditional angiography [9.5 mL (IQR 2-19.5) versus 19.5 mL (IQR 15-30), P = 0.03)] and maintained equivalent technical success rates (92.2% vs. 91.7%, P = 0.9). CONCLUSIONS: The adjunctive use of carbon dioxide angiography allows for significantly less contrast administration compared with standard angiography while achieving an equivalent rate of technical success. Selective carbon dioxide angiography should be considered a first-line modality for patients with TRAS in need of endovascular therapy.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Elmously A, Stern JR, Greenberg J, et al. Carbon Dioxide Angiography in the Treatment of Transplant Renal Artery Stenosis. Ann Vasc Surg. 2019. PMID: 31626944. doi:10.1016/j.avsg.2019.08.085

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。